skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Refinado por: assunto: Biological And Medical Sciences remover Base de dados/Biblioteca: EBSCO_MEDLINE Complete（医学期刊全文数据库） remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Leukemic Stem Cells: A Review
Leukemic Stem Cells: A Review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Leukemic Stem Cells: A Review

O'Brien, J. A. ; Rizzieri, D. A.

Cancer investigation, 2013-05, Vol.31 (4), p.215-220 [Periódico revisado por pares]

New York, NY: Informa Healthcare

Texto completo disponível

Citações Citado por
2
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

KHOURY, H. J ; KUKREJA, M ; GALE, R. P ; MARKS, D. I ; MCCARTHY, P. L ; WOOLFREY, A ; SZER, J ; GIRALT, S. A ; MAZIARZ, R. T ; CORTES, J ; HOROWITZ, M. M ; LEE, S. J ; GOLDMAN, J. M ; WANG, T ; HALTER, J ; ARORA, M ; GUPTA, V ; RIZZIERI, D. A ; GEORGE, B ; KEATING, A

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.810-816 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment

KANDA, J ; KAYNAR, L ; GASPARETTO, C ; CHUTE, J. P ; MORRIS, A ; WINKEL, S ; MCPHERSON, J ; KURTZBERG, J ; CHAO, N. J ; HORWITZ, M. E ; KANDA, Y ; PRASAD, V. K ; PARIKH, S. H ; LAN, L ; SHEN, T ; RIZZIERI, D. A ; LONG, G. D ; SULLIVAN, K. M

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.926-931 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

ARMAND, Philippe ; NAGLER, Arnon ; FAY, Joseph W ; RIZZIERI, David A ; HOSING, Chitra M ; BALL, Edward D ; UBERTI, Joseph P ; LAZARUS, Hillard M ; MAPARA, Markus Y ; GREGORY, Stephanie A ; TIMMERMAN, John M ; ANDORSKY, David ; WELLER, Edie A ; OR, Reuven ; WALLER, Edmund K ; ROTEM-YEHUDAR, Rinat ; GORDON, Leo I ; DEVINE, Steven M ; AVIGAN, David E ; CHEN, Yi-Bin ; KAMINSKI, Mark S ; KENT HOLLAND, H ; WINTER, Jane N ; MASON, James R

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4199-4206 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells

JORDAN, C. T ; UPCHURCH, D ; LUGER, S. M ; PHILLIPS, G. L ; SZILVASSY, S. J ; GUZMAN, M. L ; HOWARD, D. S ; PETTIGREW, A. L ; MEYERROSE, T ; ROSSI, R ; GRIMES, B ; RIZZIERI, D. A

Leukemia, 2000-10, Vol.14 (10), p.1777-1784 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
6
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration

HORWITZ, M. E ; CHUTE, J. P ; GASPARETTO, C ; LONG, G. D ; MCDONALD, C ; MORRIS, A ; RIZZIERI, D. A ; SULLIVAN, K. M ; CHAO, N. J

Bone marrow transplantation (Basingstoke), 2012-08, Vol.47 (8), p.1051-1055 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure

DUVAL, Michel ; KLEIN, John P ; KEATING, Armand ; LAZARUS, Hillard M ; LITZOW, Mark R ; MARKS, David I ; MAZIARZ, Richard T ; RIZZIERI, David A ; SCHILLER, Gary ; SCHULTZ, Kirk R ; TALLMAN, Martin S ; WEISDORF, Daniel ; WENSHENG HE ; CAHN, Jean-Yves ; CAIRO, Mitchell ; CAMITTA, Bruce M ; KAMBLE, Rammurti ; COPELAN, Edward ; DE LIMA, Marcos ; GUPTA, Vikas

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3730-3738 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation

KANDA, J ; HORWITZ, M. E ; RIZZIERI, D. A ; LONG, G. D ; GASPARETTO, C ; SULLIVAN, K. M ; CHUTE, J. P ; MORRIS, A ; HENNIG, T ; LI, Z ; CHAO, N. J

Bone marrow transplantation (Basingstoke), 2012-05, Vol.47 (5), p.700-705 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality
Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality

FENSKE, Timothy S ; ZHANG, Mei-Jie ; HOLMBERG, Leona A ; INWARDS, David J ; LAZARUS, Hillard M ; MAZIARZ, Richard T ; MUNKER, Reinhold ; PERALES, Miguel-Angel ; RIZZIERI, David A ; SCHOUTEN, Harry C ; SMITH, Sonali M ; WALLER, Edmund K ; CARRERAS, Jeanette ; WIRK, Baldeep M ; LAPORT, Ginna G ; MALONEY, David G ; MONTOTO, Silvia ; HARI, Parameswaran N ; AYALA, Ernesto ; BURNS, Linda J ; CASHEN, Amanda ; COSTA, Luciano J ; FREYTES, César O ; GALE, Robert P ; HAMADANI, Mehdi

Journal of clinical oncology, 2014-02, Vol.32 (4), p.273-281 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial
Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial

FADERL, Stefan ; WETZLER, Meir ; MARIS, Michael ; KOVACSOVICS, Tibor ; GOLDBERG, Stuart ; SEITER, Karen ; HARI, Parameswaran ; GREINER, Jochen ; VEY, Norbert ; RECHER, Christian ; RAVANDI, Farhad ; WANG, Eunice S ; RIZZIERI, David ; VASCONCELLES, Michael ; HUEBNER, Dirk ; KANTARJIAN, Hagop M ; SCHILLER, Gary ; JAGASIA, Madan ; STUART, Robert ; GANGULY, Siddhartha ; AVIGAN, David ; CRAIG, Michael ; COLLINS, Robert

Journal of clinical oncology, 2012-07, Vol.30 (20), p.2492-2499 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1997  (4)
  2. 1997Até2000  (13)
  3. 2001Até2004  (31)
  4. 2005Até2009  (96)
  5. Após 2009  (92)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.